Department of Clinical Laboratory, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, China.
Department of Clinical Laboratory, Liaocheng People's Hospital and Liaocheng Clinical School of Taishan Medical University, China.
Biomed Pharmacother. 2018 Aug;104:832-840. doi: 10.1016/j.biopha.2018.03.013. Epub 2018 Mar 19.
The important role of miR-422a in tumor has been reported in several studies. Recent research discovered that the expression of miR-422a was significantly decreased in colorectal cancer tissues, providing miR-422a as a tumor suppressor in CRC. However, the concrete mechanism of miR-422a regulating CRC cell is still unclear. In this study, we demonstrated that miR-422a could inhibit CRC cell growth and promote cell apoptosis via in vitro analyses. Moreover, computational methods were adopted to identify the targets of miR-422a. We found MAPKK6 was the direct target of miR-422a. Consequently, we further elucidated that miR-422a inhibited CRC cell growth and induced cell apoptosis by inhibiting p38/MAPK pathway. Besides that, we established the tumor xenograft model using nude mice and the inhibitory effects on tumor volumes and weights by miR-422a mimic transfection were also detected. Taken together, these findings demonstrated miR-422a exerted anti-cancer activities on CRC, which could be potentially used for CRC prognosis prediction and treatment.
已有多项研究报道 miR-422a 在肿瘤中的重要作用。最近的研究发现,miR-422a 在结直肠癌组织中的表达明显降低,提示 miR-422a 是 CRC 的肿瘤抑制因子。然而,miR-422a 调节 CRC 细胞的具体机制尚不清楚。本研究通过体外分析证实 miR-422a 可抑制 CRC 细胞生长并促进细胞凋亡。此外,还采用计算方法鉴定了 miR-422a 的靶标。我们发现 MAPKK6 是 miR-422a 的直接靶标。因此,我们进一步阐明 miR-422a 通过抑制 p38/MAPK 通路抑制 CRC 细胞生长并诱导细胞凋亡。此外,我们还建立了裸鼠肿瘤异种移植模型,检测 miR-422a 模拟物转染对肿瘤体积和重量的抑制作用。综上所述,这些发现表明 miR-422a 对 CRC 具有抗癌活性,可用于 CRC 的预后预测和治疗。